Connect Sign In
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for osteoporosis, paraneoplastic pemphigus, and epilepsy.
Forbes magazine has listed ARUP as one of the 2023 Best Employers by State based on employer recommendations from employees and others in Utah in a recent survey conducted by Statista.
Ragan Communications has recognized an ARUP program that helps staff improve their health through exercises that treat and prevent injuries that can result from the repetitive nature of work in a lab.
ARUP is gearing up for the launch of a new hematopathology webinar to be hosted by Madhu Menon, MD, PhD, FCAP. Other ARUP experts will join Menon to discuss timely issues in hematopathology testing.
A novel event organized by ARUP’s Patent Committee aimed to highlight creative solutions that may not lead to patents but still advance laboratory medicine and improve patient care.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for Lyme disease, diagnosing pneumonia, and evaluating infertility.
ARUP researchers and medical directors will join industry leaders at AACC 2023 to share their expertise on laboratory stewardship, workforce needs, automation, and more.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for human papillomavirus, chronic lymphocytic leukemia, and amenorrhea.
Valerie Collier, MS, CGC, will present insights on the DEX MolDx program and how to submit Z-Code applications under new private payer Z-Code requirements as an expert panelist in an upcoming webinar.
Black Physicians of Utah and ARUP recently hosted a Summer Research Day to give undergraduate and high school students a chance to tour labs, meet medical directors, and learn more about lab testing.
Blood donor centers across the country struggle to fulfill hospital demand for blood in the summer. ARUP Blood Services will host three public blood drives this summer to help patients in need.
ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials that led to FDA approval for AYVAKIT® (avapritinib), a new treatment for indolent systemic mastocytosis.
